2019 Annual Global Virtual Cancer Conference pdf Brochure My good cancer buddy and testicular cancer advocate, Justin Birkbichler www.aballsysenseofhumor.com just asked me to fill in on the panel 'Brothers in Battle' session for the Global Virtual Cancer Conference this coming week-end; I am honored to do. I can't tell you too much about this virtual […]
This group is for men with complex disease either at diagnosis, or whose disease has recurred with or without evidence of metastasis. With men who have experienced the gamut of treatments, we discuss status, as well as new developments in treatment and technology. New participants are given priority to discuss their situation. 1st & 3rd Mondays […]
(AnCan strongly endorses this event presented by our prostate cancer partner, UsTOO. It features excellent speakers including one of our 'all-time favorites', genitourinary medical oncologist Dr. Alicia Morgans, as well as Dr. Maha Hussein. Please note this event is available LIVE in the Chicago Loop and by WEBINAR.) UsTOO presents PROSTATE CANCER PATHWAYS Free […]
Back in mid-2012, the US Preventative Services Task Force first made the following recommendation with an associated D Grade:
The U.S. Preventive Services Task Force (USPSTF) recommends against prostate-specific antigen (PSA)–based screening for prostate cancer.
Back in mid-2012, the US Preventative Services Task Force first made the following recommendation with an associated D Grade:
The U.S. Preventive Services Task Force (USPSTF) recommends against prostate-specific antigen (PSA)–based screening for prostate cancer.
Back in mid-2012, the US Preventative Services Task Force first made the following recommendation with an associated D Grade:
The U.S. Preventive Services Task Force (USPSTF) recommends against prostate-specific antigen (PSA)–based screening for prostate cancer.
Back in mid-2012, the US Preventative Services Task Force first made the following recommendation with an associated D Grade:
The U.S. Preventive Services Task Force (USPSTF) recommends against prostate-specific antigen (PSA)–based screening for prostate cancer.
Back in mid-2012, the US Preventative Services Task Force first made the following recommendation with an associated D Grade:
The U.S. Preventive Services Task Force (USPSTF) recommends against prostate-specific antigen (PSA)–based screening for prostate cancer.
June 19th @ 10 am Eastern Most who particpate in AnCan's programs know we are massive proponents of involving palliative care, or as UCSF calls it 'Symptom Management'', early in your treatment path - so we stronlgly recommend attending this CureTalk webinar. Dr. Mike is a good friend of AnCan, as is CureTalk - so […]
